Non-small cell lung cancer
Conditions
Interventions
earlier-stage NSCLC patients:None
Sponsors
Beijing Cancer Hospital
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. Patients with histologically or cytologically newly confirmed diagnosis of Stage IB-IIIC NSCLC using American Joint Committee on Cancer (AJCC) criteria v8.0 during 01-Jan-2019 to 31-Dec-2021; 2. Patients aged >= 18 years at first diagnosis of Stage IB-IIIC NSCLC; 3. Patients with at least 2 visits record whose data are accessible for research purposes during the study observation period.
Exclusion criteria
Exclusion criteria: 1. Patients enrolled in interventional clinical trials at any time during the study period; 2. Evidence of any other primary cancer diagnosis prior to initial NSCLC diagnosis, unless in remission for > 5 years; 3. No specific medical record of diagnostic time of disease.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Treatment pattern;Real-world time on treatment (rwToT);Time to initial treatment after being diagnosed as NSCLC; | — |
Secondary
| Measure | Time frame |
|---|---|
| Demographics and clinical characteristics;Down-staging proportion;The average post-operative length of hospital stays ; | — |
Countries
China
Contacts
Public ContactNan Wu
Beijing Cancer Hospitial
Outcome results
None listed